La FDA aprueba a un competidor del Bótox que dura más tiempo
VIERNES, 9 de septiembre de 2022 (HealthDay News) — Las personas que deseen mantener las arrugas a raya pronto tendrán una nueva opción, ahora que la Administración de Alimentos y Medicamentos (FDA) de EE. UU. aprobó al primer competidor del Bótox en…
Learn MoreFDA Approves Botox Competitor That Lasts Longer
FRIDAY, Sept. 9, 2022 (HealthDay News) — People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.Daxxify, made by Revance Therapeutics In…
Learn MoreFDA Approves Botox Competitor That Lasts Longer
FRIDAY, Sept. 9, 2022 (HealthDay News) — People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.Daxxify, made by Revance Therapeutics In…
Learn More